“dQ&A’s research is the most robust and insightful review of the diabetes market available.”
Suggested Articles
Patients Weathering Chaos but Seeing Results When Starting Mounjaro, According to Proprietary dQ&A® First Look Research
Mounjaro is a once weekly injectable medicine approved for adults with type 2 diabetes to be used along with diet and exercise to improve blood sugar…
Time in Range Outcomes from Six European Countries
Our European research…
Eight dQ&A® Abstracts Presented at ATTD 2023
We are excited to announce that…
